Noble CO - Search Results

1

Clinical development of histone deacetylase inhibitors as anticancer agents.

Drummond DC, Noble CO, Kirpotin DB, Guo Z, Scott GK, Benz CC. Drummond DC, et al. Among authors: noble co. Annu Rev Pharmacol Toxicol. 2005;45:495-528. doi: 10.1146/annurev.pharmtox.45.120403.095825. Annu Rev Pharmacol Toxicol. 2005. PMID: 15822187 Review.

2

Development of ligand-targeted liposomes for cancer therapy.

Noble CO, Kirpotin DB, Hayes ME, Mamot C, Hong K, Park JW, Benz CC, Marks JD, Drummond DC. Noble CO, et al. Expert Opin Ther Targets. 2004 Aug;8(4):335-53. doi: 10.1517/14728222.8.4.335. Expert Opin Ther Targets. 2004. PMID: 15268628 Review.

3

Enhanced pharmacodynamic and antitumor properties of a histone deacetylase inhibitor encapsulated in liposomes or ErbB2-targeted immunoliposomes.

Drummond DC, Marx C, Guo Z, Scott G, Noble C, Wang D, Pallavicini M, Kirpotin DB, Benz CC. Drummond DC, et al. Clin Cancer Res. 2005 May 1;11(9):3392-401. doi: 10.1158/1078-0432.CCR-04-2445. Clin Cancer Res. 2005. PMID: 15867240

4

Gadolinium-loaded liposomes allow for real-time magnetic resonance imaging of convection-enhanced delivery in the primate brain.

Saito R, Krauze MT, Bringas JR, Noble C, McKnight TR, Jackson P, Wendland MF, Mamot C, Drummond DC, Kirpotin DB, Hong K, Berger MS, Park JW, Bankiewicz KS. Saito R, et al. Exp Neurol. 2005 Dec;196(2):381-9. doi: 10.1016/j.expneurol.2005.08.016. Epub 2005 Sep 28. Exp Neurol. 2005. PMID: 16197944

5

Genospheres: self-assembling nucleic acid-lipid nanoparticles suitable for targeted gene delivery.

Hayes ME, Drummond DC, Kirpotin DB, Zheng WW, Noble CO, Park JW, Marks JD, Benz CC, Hong K. Hayes ME, et al. Among authors: noble co. Gene Ther. 2006 Apr;13(7):646-51. doi: 10.1038/sj.gt.3302699. Gene Ther. 2006. PMID: 16341056

6

Epidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivo.

Mamot C, Drummond DC, Noble CO, Kallab V, Guo Z, Hong K, Kirpotin DB, Park JW. Mamot C, et al. Among authors: noble co. Cancer Res. 2005 Dec 15;65(24):11631-8. doi: 10.1158/0008-5472.CAN-05-1093. Cancer Res. 2005. PMID: 16357174

7

Tissue affinity of the infusate affects the distribution volume during convection-enhanced delivery into rodent brains: implications for local drug delivery.

Saito R, Krauze MT, Noble CO, Tamas M, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Saito R, et al. Among authors: noble co. J Neurosci Methods. 2006 Jun 30;154(1-2):225-32. doi: 10.1016/j.jneumeth.2005.12.027. Epub 2006 Feb 10. J Neurosci Methods. 2006. PMID: 16472868

8

Novel nanoliposomal CPT-11 infused by convection-enhanced delivery in intracranial tumors: pharmacology and efficacy.

Noble CO, Krauze MT, Drummond DC, Yamashita Y, Saito R, Berger MS, Kirpotin DB, Bankiewicz KS, Park JW. Noble CO, et al. Cancer Res. 2006 Mar 1;66(5):2801-6. doi: 10.1158/0008-5472.CAN-05-3535. Cancer Res. 2006. PMID: 16510602

9

Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy.

Drummond DC, Noble CO, Guo Z, Hong K, Park JW, Kirpotin DB. Drummond DC, et al. Among authors: noble co. Cancer Res. 2006 Mar 15;66(6):3271-7. doi: 10.1158/0008-5472.CAN-05-4007. Cancer Res. 2006. PMID: 16540680

10

Convection-enhanced delivery of Ls-TPT enables an effective, continuous, low-dose chemotherapy against malignant glioma xenograft model.

Saito R, Krauze MT, Noble CO, Drummond DC, Kirpotin DB, Berger MS, Park JW, Bankiewicz KS. Saito R, et al. Among authors: noble co. Neuro Oncol. 2006 Jul;8(3):205-14. doi: 10.1215/15228517-2006-001. Epub 2006 May 24. Neuro Oncol. 2006. PMID: 16723630 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters